Han Kim

Company: Bolt Biotherapeutics

Job title: In Vivo Pharmacology

Seminars:

Discovering the In Vivo Pharmacology of Bolt Biotherapeutics’ Immune Checkpoint Modulator ADC: BoltbodyTM Immune-Stimulating Antibody Conjugates (ISACs) for Solid Tumors 3:00 pm

Delving in to the pre-clinical story and in vivo pharmacology of our Boltbody immune stimulating ADC Understanding translational challenges and potential hurdles working with immunestimulating ADCs What is the future for the Boltbody ADC for solid tumors?Read more

day: Conference Day Two